CERO THERAPEUTICS HOLDINGS, INC. Other Payments to Acquire Businesses
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Other Payments to Acquire Businesses of $50.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:OtherPaymentsToAcquireBusinesses · last filed 2024-04-02
- CERO THERAPEUTICS HOLDINGS, INC. other payments to acquire businesses for fiscal 2023 was $50.00M.
| Period end | Other Payments to Acquire Businesses 6 month | Other Payments to Acquire Businesses 12 month |
|---|---|---|
| 2023-12-31 | $50.00M 10-K · filed 2024-04-02 | |
| 2023-06-30 | $50.00M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |